Your session is about to expire
← Back to Search
Pap smears using the Papette for Cervical Cancer Screening
N/A
Waitlist Available
Led By Danielle O'Laughlin, PA-C, MS
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial is comparing different ways of collecting cells from the cervix to screen for cancer. The Papette brush is being compared to the traditional spatula and cytology brush.
Eligible Conditions
- Cervical Cancer Screening
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Specimen Adequacy
Secondary outcome measures
Cervical Bleeding With Collection
Collection Time
Perceived Pain
Trial Design
2Treatment groups
Experimental Treatment
Group I: Pap smears using the traditional spatula/cytology brushExperimental Treatment1 Intervention
Spatula/cytology brush used to collect a Pap smear sample as standard of care.
Group II: Pap smears using the PapetteExperimental Treatment1 Intervention
Papette brush used to collect a Pap smear sample as standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Papette brush collection
2021
N/A
~760
Spatula/cytology brush collection
2021
N/A
~760
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,766,384 Total Patients Enrolled
Danielle O'Laughlin, PA-C, MSPrincipal InvestigatorMayo Clinic
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger